{"id":"https://openalex.org/W1972190056","doi":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","title":"Nitritoid reaction in a patient on ACE inhibitor and Myocrisin treatments","display_name":"Nitritoid reaction in a patient on ACE inhibitor and Myocrisin treatments","publication_year":1997,"publication_date":"1997-06-01","ids":{"openalex":"https://openalex.org/W1972190056","doi":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","mag":"1972190056","pmid":"https://pubmed.ncbi.nlm.nih.gov/9227825"},"language":"en","primary_location":{"id":"doi:10.1111/j.1445-5994.1997.tb01993.x","doi":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","pdf_url":null,"source":{"id":"https://openalex.org/S124240608","display_name":"Australian and New Zealand Journal of Medicine","issn_l":"0004-8291","issn":["0004-8291"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian and New Zealand Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111805620","display_name":"D. W. T. CHING","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. W. T. CHING","raw_affiliation_strings":["Consultant Rheumatologist, Departments of Rheumatology and Pharmacy, Timaru Hospital, Timaru, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant Rheumatologist, Departments of Rheumatology and Pharmacy, Timaru Hospital, Timaru, New Zealand","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059815377","display_name":"A. D. McCLINTOCK","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. D. McCLINTOCK","raw_affiliation_strings":["Clinical Pharmacist, Departments of Rheumatology and Pharmacy, Timaru Hospital, Timaru, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacist, Departments of Rheumatology and Pharmacy, Timaru Hospital, Timaru, New Zealand","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2065,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.4880869,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"3","first_page":"343","last_page":"343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.44339999556541443,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.44339999556541443,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.04960000142455101,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.04769999906420708,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.652999997138977},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.47099998593330383},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5080000162124634},{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibition","display_name":"nitric oxide synthase inhibition","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6685652732849121},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.631996750831604},{"id":"https://openalex.org/C2779457091","wikidata":"https://www.wikidata.org/wiki/Q105186","display_name":"Pharmacist","level":3,"score":0.6189385652542114},{"id":"https://openalex.org/C10446079","wikidata":"https://www.wikidata.org/wiki/Q155491","display_name":"Clinical pharmacy","level":3,"score":0.5206598043441772},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.49092796444892883},{"id":"https://openalex.org/C2778805511","wikidata":"https://www.wikidata.org/wiki/Q1713","display_name":"Citation","level":2,"score":0.468520849943161},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4409838318824768},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.43516066670417786},{"id":"https://openalex.org/C190857496","wikidata":"https://www.wikidata.org/wiki/Q388618","display_name":"Hospital pharmacy","level":3,"score":0.4283450245857239},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.3737715780735016},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000707","descriptor_name":"Anaphylaxis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010292","descriptor_name":"Paresthesia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012971","descriptor_name":"Gold Sodium Thiosulfate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D017706","descriptor_name":"Lisinopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1445-5994.1997.tb01993.x","doi":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1445-5994.1997.tb01993.x","pdf_url":null,"source":{"id":"https://openalex.org/S124240608","display_name":"Australian and New Zealand Journal of Medicine","issn_l":"0004-8291","issn":["0004-8291"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian and New Zealand Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:9227825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9227825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian and New Zealand journal of medicine","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2404748286","https://openalex.org/W580616401","https://openalex.org/W2473112236","https://openalex.org/W2400083129","https://openalex.org/W3147115707","https://openalex.org/W4298173208","https://openalex.org/W4231522353","https://openalex.org/W2417579167","https://openalex.org/W2027884554","https://openalex.org/W2102284993"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}